Connect your AI

Innoviva, Inc. INVA Change in Other Assets

Change in Other Assets at other companies

PfizerPFE

-$322.25M+61.9%

InsmedINSM

$2.36M+123%

SavaraSVRA

$639K+174%

ArriVent BioPharma, Inc.AVBP

$2.56M+61.0%

LQD

Liquidia CorporationLQDA

$4.6M-0.5%

ZymeworksZYME

$1.73M+160%

Other financials

Income statement

Revenue$98.0M+10.6%

Gross profit$75.8M+3.4%

Operating income$38.2M-7.9%

Net income$186.6M+501%

EPS (diluted)$2.22+400%

Balance sheet

Cash & equivalents$603.1M+89.0%

Total debt$269.4M-40.3%

Total equity$1.3B—

Total assets$1.8B+46.4%

Cash flow

Operating cash flow$35.3M-27.4%

CapEx$492.0K—

Free cash flow$34.8M-28.4%

Valuation

Market cap$1.74B+51.8%

Enterprise value$1.41B+9.7%

P/E3.5×—

P/S4.2×+1.0×

Profitability

Gross margin73.7%-9.9pp

Operating margin38.1%-11.2pp

Net margin119.9%+107pp

FCF margin54.1%+5.3pp

Returns & leverage

Return on equity29.1%—

Debt / equity0.2×—

Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Innoviva, Inc.'s change in other assets?: Innoviva, Inc. (INVA) reported change in other assets of $8.37M in Q1 2026.
How has Innoviva, Inc.'s change in other assets changed year-over-year?: Innoviva, Inc.'s change in other assets increased by 1618.1% year-over-year, from -$551K to $8.37M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.